Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination
- Resource Type
- Article
- Source
- In
The Lancet Regional Health - Europe March 2024 38 - Subject
Primary Research Articles - Language
- ISSN
- 2666-7762